合肥康润立合药业

Hefei Kangrun Lihe Pharmaceutical is a Chinese pharmaceutical company established in 2022 and based in Hefei, Anhui Province. The company operates primarily under the Marketing Authorization Holder (MAH) system, focusing on the registration, commercialization, and sales of pharmaceutical products. Its commercial portfolio includes Oseltamivir Phosphate Capsules, a small molecule antiviral targeting neuraminidase for the treatment of influenza, and Niuhuang Jiedu Tablets, a traditional Chinese herbal medicine used for clearing heat and relieving sore throats. Hefei Kangrun Lihe Pharmaceutical outsources its manufacturing to contract manufacturing partners, including Huayi Pharmaceutical Technology, Anhui Guosen Pharmaceutical, and Maoxiang Group Jilin Pharmaceutical.